Priority,Rule
High,"Osimertinib, Tagrisso, Savolitinib, Datopotamab deruxtecan, Dato-DXd, Datroway, HER3-DXd, patritumab deruxtecan, TROP2 (and ADC), HER3, EGFR Bispecifics, Sunvozertinib, Zipalertinib, Firmonertinib, Furmonertinib, Ivonescimab, Sac-TMT, sacituzumab tirumotecan, MK-2870, SKB-264, SKB264, MCLA-129 or pamvatami, AZD-9592 or AZD9592 or tilatamig samrotecan, BL-B01D1 or izalontamab brengitecan, SI-B-001 or izalontamab "
Medium,"4th-Gen (fourth-gen) EGFR TKIs, ALK, ROS1, KRAS-G12C and NSCLC, any ADC for lung (NSCLC or SCLC)"
